tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Cash flow

Compare
185 Followers

SAB Biotherapeutics Cash Flow

SABS's free cash flow for Q3 2025 was $-13.05M. For the 2025 fiscal year, SABS's free cash flow was decreased by $-9.31M and operating cash flow was $-13.05M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -34.29M$ -25.12M$ -23.46M$ 1.99M$ 10.00M
Investing Cash Flow
$ -11.96M$ -152.70K$ -2.09M$ -10.94M$ -12.72M
Financing Cash Flow
$ -1.17M$ 66.77M$ 1.05M$ 35.89M$ 8.98M
End Cash Position
$ 8.90M$ 56.57M$ 15.05M$ 39.55M$ 12.61M
Free Cash Flow
$ -34.63M$ -25.32M$ -25.63M$ -8.96M$ -2.73M
Currency in USD

SAB Biotherapeutics Cash Flow